The integrity of the blood-brain barrier in Alzheimer's disease

被引:57
|
作者
Algotsson, A. [1 ]
Winblad, B. [1 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Caring Sci & Soc, SE-14186 Huddinge, Sweden
来源
ACTA NEUROLOGICA SCANDINAVICA | 2007年 / 115卷 / 06期
关键词
Alzheimer's disease; blood-brain barrier; gender; plasma creatinine;
D O I
10.1111/j.1600-0404.2007.00823.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective - To evaluate the integrity of the blood-brain barrier (BBB) in incident Alzheimer's disease (AD). Materials and methods - The mean age of the 157 patients (45% men) was 69.7(9.4) years (range 51-88 years). The patients had undergone a thorough investigation including magnetic resonance imaging or computed tomography of the brain. The cerebrospinal(CSF)/plasma albumin ratio (albumin ratio) was used as a measure of BBB function. Results - There were gender differences with respect to albumin ratio and plasma creatinine with higher values in men (P < 0.001). 42% of the men and 13% of the women (P < 0.001) had a mild to moderate BBB dysfunction when applying the reference limit of the laboratory ( < 9.2). Both male gender (P = 0.002) and plasma creatinine (P = 0.009) were independently associated with the albumin ratio when controlling for putative confounders. Conclusions - The BBB is dysfunctional in a portion of patients with AD, both women and, primarily, men. The dysfunction might influence the clearance of both harmful and beneficial substances across the barrier. Renal function might have an impact on the BBB.
引用
收藏
页码:403 / 408
页数:6
相关论文
共 50 条
  • [41] Possible effects of Porphyromonas gingivalis on the blood-brain barrier in Alzheimer's disease
    Olsen, Ingar
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (11) : 1367 - 1371
  • [42] The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?
    Pan, Yijun
    Khalil, Hanan
    Nicolazzo, Joseph A.
    CURRENT CLINICAL PHARMACOLOGY, 2015, 10 (03): : 222 - 241
  • [43] Blood-brain barrier link to human cognitive impairment and Alzheimer's disease
    Barisano, Giuseppe
    Montagne, Axel
    Kisler, Kassandra
    Schneider, Julie A.
    Wardlaw, Joanna M.
    Zlokovic, Berislav V.
    NATURE CARDIOVASCULAR RESEARCH, 2022, 1 (02): : 108 - 115
  • [44] siRNA drug delivery across the blood-brain barrier in Alzheimer's disease
    Sajid, Muhammad Imran
    Sheikh, Fahad Sultan
    Anis, Faiza
    Nasim, Nourina
    Sumbria, Rachita K.
    Nauli, Surya M.
    Tiwari, Rakesh Kumar
    ADVANCED DRUG DELIVERY REVIEWS, 2023, 199
  • [45] Immunotherapy and neuroimmunology in Alzheimer's disease: a perspective from the blood-brain barrier
    Banks, William A.
    IMMUNOTHERAPY, 2010, 2 (01) : 1 - 3
  • [46] Editorial: Imaging of the blood-brain barrier in Alzheimer's disease and related disorders
    Uchida, Yuto
    Shao, Xingfeng
    Montagne, Axel
    Matsukawa, Noriyuki
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [47] Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies
    Alkhalifa, Amer E.
    Al-Ghraiybah, Nour F.
    Odum, Julia
    Shunnarah, John G.
    Austin, Nataleigh
    Kaddoumi, Amal
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [48] Blood-brain barrier P-glycoprotein function in Alzheimer's disease
    van Assema, Danielle M. E.
    Lubberink, Mark
    Bauer, Martin
    van der Flier, Wiesje M.
    Schuit, Robert C.
    Windhorst, Albert D.
    Comans, Emile F. I.
    Hoetjes, Nikie J.
    Tolboom, Nelleke
    Langer, Oliver
    Mueller, Markus
    Scheltens, Philip
    Lammertsma, Adriaan A.
    van Berckel, Bart N. M.
    BRAIN, 2012, 135 : 181 - 189
  • [49] Upregulation of ribosome complexes at the blood-brain barrier in Alzheimer's disease patients
    Suzuki, Masayoshi
    Tezuka, Kenta
    Handa, Takumi
    Sato, Risa
    Takeuchi, Hina
    Takao, Masaki
    Tano, Mitsutoshi
    Uchida, Yasuo
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2022, 42 (11): : 2134 - 2150
  • [50] Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier"
    Simpkins, James W.
    ALZHEIMERS & DEMENTIA, 2009, 5 (05) : 433 - 434